MARC record from Internet Archive

LEADER: 07671cam 2200805 a 4500
001 ocm57626002
003 OCoLC
005 20200422204544.0
008 030221s2005 enka b 001 0 eng
040 $aNLM$beng$cNLM$dUKM$dBAKER$dMUQ$dNLGGC$dYDXCP$dCGC$dBTCTA$dOCLNG$dUBY$dHEBIS$dBDX$dOCLCF$dOCLCQ$dOCLCO$dUZ0$dUKMGB$dOCLCQ$dOCLCO$dOCLCA$dL2U$dOCLCA
015 $aBnb
015 $aGBA3X3394$2bnb
016 7 $a101237283$2DNLM
016 7 $a007052179$2Uk
019 $a52195453$a57201419$a1062041183
020 $a9781841841458
020 $a1841841455
035 $a(OCoLC)57626002$z(OCoLC)52195453$z(OCoLC)57201419$z(OCoLC)1062041183
042 $anlmcopyc
050 4 $aRB145$b.T49 2005
060 00 $a2004 O-253
060 10 $aWH 525$bT355 2005
082 04 $a616.15075$222
084 $a44.86$2bcl
245 00 $aTextbook of malignant hematology /$cedited by Laurent Degos, David C. Linch, Bob Lo wenberg.
246 30 $aMalignant hematology
250 $a2nd ed.
260 $aLondon ;$aNew York :$bTaylor & Francis,$c2005.
300 $axiv, 8, 876 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
520 $aThis concise overview of malignant haematology includes reviews of cell and molecular biology, and implications for new trends in treatment. The concluding section of the book contains a discussion of individual disease entities and their management.
505 00 $g1.$tThe stem cell /$rRob E. Ploemacher and Elaine A. Dzierzak --$g2.$tStem cell plasticity /$rBalkrishna N. Jahagirdar and Catherine M. Verfaillie --$g3.$tCytokine receptors and signal transduction /$rIvo P. Touw and Thamar B. van Dijk --$g4.$tCell cycle regulation /$rN. Shaun and B. Thomas --$g5.$tTranscription factors in hematopoietic differentiation and leukemia /$rMichael A. Chapman and Anthony R. Green --$g6.$tCellular aspects of lymphoid differentiation : B cells /$rClaudine Schiff and Michael Fougereau --$g7.$tCellular aspects of lymphoid differentiation : T and TK cells /$rAnne Cambiaggi, Sophie Ugolini and Eric Vivier --$g8.$tDendritic cell development /$rMax Schnurr, Eugene Maraskovsky and Jonathan Cebon --$g9.$tGranulomonopoiesis /$rWillem E. Fibbe and Rob E. Ploemacher --$g10.$tErythropoiesis /$rPaul-Henri Romeo --$g11.$tMegakaryocyte differentiation and regulation /$rWilliam Vainchenker, Najet Debili and Francoise Wendling --$g12.$tDNA repair and malignant hematopoiesis /$rLeineke R. van Veelan, Roland Kanaar and D.C. van Gent --$g13.$tSenescence and telomeres /$rPeter M. Lansdorp --$g14.$tAngiogenesis and tumor development /$rWilliam T. Bellamy --$g15.$tLymphoproliferations associated with human T-cells leukemia/lymphoma virus type I and II infection /$rAntoine Gessain and Renaud Mahieux --$g16.$tImmunosuppression : Epstein-Barr and other herpesviruses in hematological malignancies /$rMartine Raphael, Fanny Baran-Marszak and Helene A. Poirel --$g17.$tAcquired genetic changes in myeloid malignancies /$rCristina Mecucci and Anne Hagemeijer --$g18.$tCytogenetic and molecular abnormalities in lymphoid maligancies /$rWilliam Slaytor and Stephen P. Hunger --$g19.$tAnalysis of clonality using X-chromosome inactivation patterns /$rRosemary E. Gale --$g20.$tMicroarray analysis and expression profiling /$rTorsten Haferlach, Wolfgang Kern, Alexander Kohlmann, Susanne Schnittger and Claudia Schoch --$g21.$tDetection of minimal residual disease in lymphoid malignancies /$rJacques J.M. van Dongen, Tomasz Szczepanski, V.H.J. van der Velden and Anton W. Langerak --$g22.$tDetection of minimal residual disease in myeloid malignancies /$rJesus Fernando San Miguel, Marcos Gonzalez and Alberto Orfao --$g23.$tDrug resistance and its modification in hematological malignancies /$rJean-Pierre Marie --$g24.$tThe theoretical basis of chemotherapy for hematological maliganancy /$rAndrew K. McMillan and David C. Linch --$g25.$tHumoral immunotherapy and the use of monoclonal antibodies /$rPeter T. Daniel --$g26.$tT-cell-mediated immunotherapy of cancer /$rReink Offringa, Rene E.M. Toes, Maaike E. Ressing, Marloes L.H. de Bruijn and Cornelius J.M. Melief --$g27.$tInterference with signaling pathways in malignant disease /$rAsim Khwaja --$g28.$tGene transfer in leukemia and related disorders /$rMartin Pule and Malcolm Brenner --$g29.$tAllogeneic stem cell transplantation /$rRichard J. O'Reilly, Esperanza B. Papadopoulos, Trudy N. Small and Stephen Mackinnon --$g30.$tEpidemiology /$rJorgen H. Olsen --$g31.$tLymphoid malignancies in children /$rRaul C. Ribeiro and Ching-Hon Pui --$g32.$tAcute lymphoblastic leukemia in adults /$rDieter Hoelzer and Nicola Gokbuget --$g33.$tChronic lymphoid leukemias /$rEmilio Montserrat --$g34.$tMultiple myeloma /$rNikhil C. Munshi and Kenneth C. Anderson --$g35.$tHodgkin lymphoma /$rKarolin Behringer, Volger Diehl and Andreas Engert --$g36.$tNon-Hodgkin lymphomas /$rAnton Hagenbeek and Philip M. Kluin --$g37.$tAcute myeloid leukemia in children and adolescents /$rGertjan J.L. Kaspers and Yaddanapudi Ravindranath --$g38.$tAcute myeloid leukemia in adults /$rBob Lowenberg and Alan K. Burnett --$g39.$tAcute promyelocytic leukemia /$rLaurent Degos --$g40.$tMyelodysplastic syndromes /$rPierre Fenaux and Claude Gardin --$g41.$tChronic myeloid leukemia /$rFrancois Guilhot and Lydia Roy --$g42.$tChronic myeloid disorders, excluding CML /$rTiziano Barbui, Guido Finazzi and Giovanni Barosi --$g43.$tLate effects after treatment for Hodgkin lymphoma /$rAnthony J. Swerdlow and Flora E. van Leeuwen --$g44.$tLate effects in children treated for acute leukemia /$rStuart Mucklow and Gill Levitt --$g45.$tLate effects following allogeneic stem cell transplantation /$rGerard Socie and Lionel Ades --$g46.$tHematopoietic growth factors /$rStephen Devereux and Antonio Pagliuca --$g47.$tManagement of infectious complications in hematological patients /$rCatherine Cordonnier --$gApp. I.$tSelected lineage-associated antigens in hematopoietic cells : CD nomenclature --$gApp. II.$tConcise summary of the cytokines involved in human hematopoiesis.
650 0 $aHematology.
650 0 $aBlood$xDiseases$xDiagnosis.
650 0 $aBlood$xDiseases$xTreatment.
650 12 $aHematologic Neoplasms.
650 22 $aHematologic Neoplasms$xtherapy.
650 22 $aHematopoiesis$xphysiology.
650 6 $aHe matologie.
650 6 $aSang$xMaladies$xDiagnostic.
650 6 $aSang$xMaladies$xTraitement.
650 7 $a44.86 haematology.$0(NL-LeOCL)077596773$2bcl
650 7 $aBlood$xDiseases$xDiagnosis.$2fast$0(OCoLC)fst00834581
650 7 $aBlood$xDiseases$xTreatment.$2fast$0(OCoLC)fst00834587
650 7 $aHematology.$2fast$0(OCoLC)fst00954904
650 7 $aKrebs$gMedizin$2gnd
650 7 $aHa matologie$2gnd
650 17 $aBloedziekten.$2gtt
650 17 $aMaligne tumoren.$2gtt
700 1 $aDegos, Laurent.
700 1 $aLinch, David C.
700 1 $aLo wenberg, B.$q(Bob),$d1946-
938 $aBaker & Taylor$bBKTY$c769.95$d.00$i1841841455$n0004150435$sactive
938 $aBrodart$bBROD$n00722774$c$769.95
938 $aBaker and Taylor$bBTCP$nBK0006789370
938 $aTaylor & Francis$bTYFR$n1841841455
938 $aYBP Library Services$bYANK$n100334590
029 0 $aNLM$b101237283
029 1 $aAU@$b000026441263
029 1 $aHEBIS$b112484484
029 1 $aNLGGC$b251066835
029 1 $aNZ1$b11771798
029 1 $aNZ1$b7666324
029 1 $aUKMGB$b007052179
029 1 $aYDXCP$b100334590
994 $aZ0$bP4A
948 $hHELD BY P4A - 67 OTHER HOLDINGS